Boehringer taps Dutch biotech for ALT pos­i­tive can­cer pact ex­ceed­ing $573M in biobucks

Boehringer In­gel­heim has inked a re­search col­lab­o­ra­tion with Tes­sel­late Bio to de­vel­op pre­ci­sion med­i­cines for can­cers that main­tain telom­ere length to sur­vive and grow. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER